|
|
Volumn 47, Issue 1, 2016, Pages 243-253
|
|
Pirfenidone for idiopathic pulmonary fibrosis: Analysis of pooled data from three multinational phase 3 trials
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PIRFENIDONE;
PLACEBO;
NONSTEROID ANTIINFLAMMATORY AGENT;
PYRIDONE DERIVATIVE;
ADULT;
AGED;
ANOREXIA;
ARTICLE;
BRONCHITIS;
CONTROLLED STUDY;
COUGHING;
DIARRHEA;
DISEASE SEVERITY;
DIZZINESS;
DRUG DOSE ESCALATION;
DRUG EFFICACY;
DRUG FATALITY;
DRUG SAFETY;
DYSPEPSIA;
DYSPNEA;
FATIGUE;
FEMALE;
FIBROSING ALVEOLITIS;
FORCED EXPIRATORY VOLUME;
FORCED VITAL CAPACITY;
GASTROESOPHAGEAL REFLUX;
GASTROINTESTINAL SYMPTOM;
HEADACHE;
HUMAN;
HYPERBILIRUBINEMIA;
HYPERTRANSAMINASEMIA;
LUNG DIFFUSION CAPACITY;
MAJOR CLINICAL STUDY;
MALE;
MIDDLE AGED;
MORTALITY;
NAUSEA;
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RASH;
RHINOPHARYNGITIS;
RISK BENEFIT ANALYSIS;
RISK REDUCTION;
SKIN MANIFESTATION;
TREATMENT DURATION;
TREATMENT OUTCOME;
TREATMENT WITHDRAWAL;
UPPER RESPIRATORY TRACT INFECTION;
VERY ELDERLY;
VOMITING;
DISEASE COURSE;
EXERCISE TEST;
IDIOPATHIC PULMONARY FIBROSIS;
INTERNATIONAL COOPERATION;
META ANALYSIS;
PATHOPHYSIOLOGY;
VITAL CAPACITY;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CLINICAL TRIALS, PHASE III AS TOPIC;
DISEASE PROGRESSION;
EXERCISE TEST;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMANS;
IDIOPATHIC PULMONARY FIBROSIS;
INTERNATIONAL COOPERATION;
MALE;
MIDDLE AGED;
PULMONARY DIFFUSING CAPACITY;
PYRIDONES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TREATMENT OUTCOME;
VITAL CAPACITY;
|
|
EID: 84954305088
PISSN: 09031936
EISSN: 13993003
Source Type: Journal
DOI: 10.1183/13993003.00026-2015 Document Type: Article |
|
Times cited : (348)
|
|
References (11)
|
